Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene

被引:33
作者
Bhuju, Sabin [1 ]
Fonseca, Leila de Souza [2 ]
Marsico, Anna Grazia [2 ]
de Oliveira Vieira, Gisele Betzler [2 ]
Sobral, Luciana Fonseca [2 ]
Stehr, Matthias [1 ]
Singh, Mahavir [1 ,3 ]
Feres Saad, Maria Helena [4 ]
机构
[1] Helmholtz Ctr Infect Res, Dept Genome Analyt, Braunschweig, Germany
[2] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil
[3] LIONEX Diagnost & Therapeut GmbH, D-38126 Braunschweig, Germany
[4] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Microbiol Celular, Rio De Janeiro, Brazil
关键词
Mycobacterium tuberculosis; Tuberculosis; Resistance; pncA gene mutation; Pyrazinamide; PHENOTYPIC CHARACTERIZATION; DRUG-RESISTANCE; SUSCEPTIBILITY; IDENTIFICATION; MECHANISMS; COMPLEX; STRAINS; TESTS;
D O I
10.1016/j.meegid.2013.06.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
It has been widely accepted, that pyrazinamide (PZA) resistance in Mycobacterium tuberculosis is correlated with mutations in the pncA gene. But since years researchers have been puzzled by the fact that up to 30% of PZA resistant strains do not show any correlation between PZA resistance and mutations in the pncA gene, and thus may vary with geographic area. The objective of the study was to investigate the correlation between PZA susceptibility and mutations in pncA gene in M. tuberculosis isolates from individuals living in a highly endemic area. Therefore we analyzed drug resistant and multidrug resistant (MDR) isolates from patients in Rio de Janeiro, Brazil. From a total of 97 clinical isolates of M. tuberculosis 35 were identified as PZA resistant, 24/35 strains did not show PZase activity and 15/24 (62.5%) strains possess mutation in the pncA gene. This is a low correlation between PZA resistance and PZase activity (68.6%) and even lower correlation between PZA resistance and the presence of mutation in pncA gene (45.7%). Most of the mutations found were conserved near the active site or metal binding site of PZase. The 146A > C mutation was found both in PZA resistant and susceptible isolates, suggesting that this mutation may not fully associated with PZA resistance. Of the mutations found, three have not been previously described. The insertions 192-193 TCCTCGTC and 388-389 AGGTCGATG, although found before, here was found to be a short tandem repeat and in one strain, insertion of the IS6110 was observed 55 nt upstream of the gene. All PZA resistant isolates had no mutation in the gene coding ribosomal protein S1 (rpsA), which has recently been proposed as alternate target for pyrazinoic acid (POA). The results show a low association of PZA resistance and pncA gene mutations in a selected patient group from an highly endemic area. Our findings point out that the phenotypic susceptibility testing remains important for the detection of PZA-resistant M. tuberculosis. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 46 条
  • [1] Gene Sequencing for Routine Verification of Pyrazinamide Resistance in Mycobacterium tuberculosis: a Role for pncA but Not rpsA
    Alexander, David C.
    Ma, Jennifer H.
    Guthrie, Jennifer L.
    Blair, Joanne
    Chedore, Pam
    Jamieson, Frances B.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (11) : 3726 - 3728
  • [2] pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil
    Barco, P.
    Cardoso, R. F.
    Hirata, R. D. C.
    Leite, C. Q. F.
    Pandolfi, J. R.
    Sato, D. N.
    Shikama, M. L.
    de Melo, F. Fiuza
    Mamizuka, E. M.
    Campanerut, P. A. Z.
    Hirata, M. H.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (05) : 930 - 935
  • [3] Bishop KS, 2001, INT J TUBERC LUNG D, V5, P952
  • [4] Molecular mechanisms of drug resistance in Mycobacterium tuberculosis
    Blanchard, JS
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 : 215 - 239
  • [5] SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS TO PYRAZINAMIDE AND ITS RELATIONSHIP TO PYRAZINAMIDASE ACTIVITY
    BUTLER, WR
    KILBURN, JO
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) : 600 - 601
  • [6] CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
  • [7] Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong
    Chan, Raphael C. Y.
    Hui, Mamie
    Chan, Edward W. C.
    Au, T. K.
    Chin, Miu. L.
    Yip, Chun K.
    AuYeang, Carrie K. W.
    Yeung, Christina Y. L.
    Kam, Kai M.
    Yip, Peter C. W.
    Cheng, Augustine E. B.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (05) : 866 - 873
  • [8] Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses
    Chang, Kwok Chiu
    Yew, Wing Wai
    Zhang, Ying
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (10) : 4499 - 4505
  • [9] Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan
    Chiu, Yu-Chi
    Huang, Shiang-Fen
    Yu, Kwok-Woon
    Lee, Yu-Chin
    Feng, Jia-Yih
    Su, Wei-Juin
    [J]. BMC INFECTIOUS DISEASES, 2011, 11
  • [10] Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains
    Dormandy, Jillian
    Somoskovi, Akos
    Kreistvirth, Barry N.
    Driscoll, Jeffrey R.
    Ashkin, David
    Salfinger, Max
    [J]. CHEST, 2007, 131 (02) : 497 - 501